ALIMATU NABIE: Open Payments
NPI 1053820621 · MONTGOMERY VILLAGE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,397 in 180 payments from 11 companies in 2025. Trend: 2023 $1,896 · 2024 $1,680 · 2025 $4,397
Food & beverage: $4,277Education: $120
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 25 | $761 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $732 |
| Otsuka America Pharmaceutical, Inc. | 22 | $555 |
| ABBVIE INC. | 24 | $420 |
| Alkermes, Inc. | 21 | $368 |
| Lundbeck LLC | 13 | $360 |
| E.R. Squibb & Sons, L.L.C. | 12 | $276 |
| Neurocrine BioSciences, Inc. | 14 | $262 |
| Supernus Pharmaceuticals, Inc. | 6 | $252 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $234 |
Products named: CAPLYTA, REXULTI, UZEDY, VRAYLAR, ARISTADA, COBENFY, INGREZZA, Qelbree.
Industry payments across MD — which companies pay providers there.
